Evidence map›Paper›PMID 34569311›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Effect of Helicobacter Pylori on Plasma Metabolic Phenotype in Patients With Gastric Cancer.

Yan-Ping Wang, Ting Wei, Xiao Ma, Xiao-Liang Zhu, Long-Fei Ren, Lei Zhang, Fang-Hui Ding, Xun Li, Hai-Ping Wang, Zhong-Tian Bai and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic Effects of Sulforaphane onInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Yan-Ping WangThe Pharmacy Department, 117741The First Hospital of Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0001-9473-1063
Ting WeiThe Pharmacy Department, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Xiao MaThe Traditional Chinese Medicine Laboratory, Gansu Institute for Drug Control, Lanzhou, China.
Xiao-Liang ZhuThe Fifth Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Long-Fei RenThe Fifth Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Lei ZhangThe Fifth Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Fang-Hui DingThe Fifth Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Xun LiThe Fifth Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Hai-Ping WangThe Key Laboratory of Biological Therapy and Regenerative Medicine Transformation Gansu Province, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Zhong-Tian BaiThe Second Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Ke-Xiang ZhuThe Second Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Long MiaoThe Second Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Jun YanThe Second Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Wen-Ce ZhouThe Second Department of General Surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Wen-Bo MengThe Department of Minimally invasive surgery, 117741The First Hospital of Lanzhou University, Lanzhou, China.
Yu-Qin LiuCancer Epidemiology Research Center, Gansu Cancer Hospital, Lanzhou, China.
First Hospital of Lanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough PURPOSE: Herein, plasma of human superficial gastritis (Hp negative and positive), early gastric cancer and advanced gastric cancer analyzed by UPLC-HDMS metabolomics can not only reveal metabolic phenotype changes in patients with gastric cancer of different degrees (30 Hp negative, 30 Hp positive, 20 early gastric cancer patients, and 10 advanced gastric cancer patients), but also auxiliarily diagnose gastric cancer.

resultsCombined with multivariate statistical analysis, the results represented biomarkers different from Hp negative, Hp positive, and the alterations of metabolic phenotype of gastric cancer patients. Forty-three metabolites are involved in amino acid metabolism, and lipid and fatty acid metabolism pathways in the process of cancer occurrence, especially 2 biomarkers glycerophosphocholine and neopterin, were screened in this study. Neopterin was consistently increased with gastric cancer progression and glycerophosphocholine tended to consistently decrease from Hp negative to advanced gastric cancer.

conclusionThis method could be used for the development of rapid targeted methods for biomarker identification and a potential diagnosis of gastric cancer.

Indexed as

Biomarkers, TumorDiagnosis, DifferentialGastritisHelicobacter pyloriHumansMetabolomicsNeoplasm StagingNeopterinPhenotypePrincipal Component AnalysisStomach NeoplasmsBiomarkers, TumorNeopterinbiomarkersgastric cancerHelicobacter pylorimetabolomics

Identifiers

PMID34569311
PMCPMC8477711
OpenAlexW3202682063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.